TWOEquity · Weekly research terminal

6130

Shangya Technology Co., Ltd.

TW Healthcare Drug Manufacturers - General

Latest week
14 Aug 2026
Weekly close
29.00 TWD
Fair value
31.69 TWD
Next-week expectancy
Negative 38.10%
Crowd view
Current verdict No votes yet Be first to vote

Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TWO · Equity · Taiwan

6130

Shangya Technology Co., Ltd.

Healthcare Drug Manufacturers - General

Shangya Technology Co., Ltd. engages in the generic drugs and solar power generation businesses in Taiwan and Asia. The company wholesales Chinese and Western medicines, medical equipment, and beauty and hair care products; and onrito, lixin fumitation, lufuxing film-coated, amperex film coating, leverb-coated, triton film-coated, special core stabilized, tanlipo film-coated, inhibitory film-coated, yoyo flat mouth dissolved, and binlishu film-coated tablet, as well as pain relief capsules and yue shi tong injection. It …

Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
TWD
Market capitalisation
1,371,699,968
Fair value reference
31.69
Next-week expectancy
Negative · 38.10%

Over the latest 12 completed weeks ending 2026-08-14, 6130 rose 32.12%, moving from 21.95 to 29.00. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -42.81 and has improved across the 12-week window. Market Dynamics is 0.64 on the latest week. Next-week expectancy is negative at 38.10% based on similar historical setup states.

Week Ending
14 Aug 2026
Latest Close
29.00
12-Week Change
32.12%
Trend Signal
Inactive
Next-Week Expectancy
Negative 38.10%
Signal Weeks
0 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
14 Aug 2026
Latest Close
29.00
12-Week Change
32.12%
Trend Signal
Inactive
Next-Week Expectancy
Negative 38.10%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
-42.81
Market Dynamics
0.64

Over the latest 12 completed weeks ending 2026-08-14, 6130 rose 32.12%, moving from 21.95 to 29.00. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -42.81 and has improved across the 12-week window. Market Dynamics is 0.64 on the latest week. Next-week expectancy is negative at 38.10% based on similar historical setup states.

Industry Peers

Taiwan equities in Drug Manufacturers - General

Stock Exchange Week Open High Low Close Change
7762 PET PHARM BIO TWO 14 Aug 2026 50.00 52.60 48.00 50.90 1.80%
4102 Yung Zip Chemical Ind. Co., Ltd. TWO 14 Aug 2026 19.05 19.15 18.50 19.10 0.26%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context